Literature DB >> 15522066

Pregnancy in essential thrombocythaemia: experience with 40 pregnancies.

Riitta Niittyvuopio1, Eeva Juvonen, Risto Kaaja, Kalevi Oksanen, Heikki Hallman, Timo Timonen, Tapani Ruutu.   

Abstract

In this study, the course of 40 pregnancies in 16 women with essential thrombocythaemia (ET) was analysed retrospectively. Of the pregnancies, 45% were complicated, 55% uncomplicated, and 62% resulted in live birth. The most common complication was spontaneous abortion during the first trimester seen in 33% of all pregnancies and comprising 72% of all complications. Two intrauterine foetal deaths occurred at weeks 22 and 28. Three pregnancies were complicated by eclampsia or pre-eclampsia. Nine of 16 women with 29 pregnancies had at least one complicated pregnancy. In seven of 16 women, all 11 pregnancies were uneventful. The non-pregnancy-related symptoms of ET or the platelet count before conception or during pregnancy did not correlate with the risk of pregnancy complications. Treatment with low-dose acetylsalicylic acid (ASA) alone during pregnancy or platelet-lowering drugs before or during pregnancy reduced the risk of complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522066     DOI: 10.1111/j.1600-0609.2004.00324.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  Spontaneous regression of essential thrombocythemia with MPL mutation on menopause.

Authors:  Maki Otsuka; Shuichi Hanada; Kayo Arita; Haruhiko Ohashi
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

Review 2.  Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.

Authors:  Kazuya Sakai; Akane Ueda; Masaaki Hasegawa; Yasunori Ueda
Journal:  Int J Hematol       Date:  2017-12-30       Impact factor: 2.490

Review 3.  Polycythaemia vera and essential thrombocythaemia: current treatment strategies.

Authors:  Elisabeth I Penninga; Ole W Bjerrum
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  How I treat essential thrombocythemia.

Authors:  Philip A Beer; Wendy N Erber; Peter J Campbell; Anthony R Green
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

Review 5.  Treatment options and pregnancy management for patients with PV and ET.

Authors:  Yoko Edahiro
Journal:  Int J Hematol       Date:  2022-04-08       Impact factor: 2.490

6.  Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.

Authors:  Lukas Schrickel; Florian H Heidel; Parvis Sadjadian; Tatjana Becker; Vera Kolatzki; Andreas Hochhaus; Martin Griesshammer; Kai Wille
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-02       Impact factor: 4.553

7.  Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.

Authors:  Dawn Maze; Sajida Kazi; Vikas Gupta; Ann Kinga Malinowski; Rouhi Fazelzad; Prakesh S Shah; Nadine Shehata
Journal:  JAMA Netw Open       Date:  2019-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.